Search for: "Pfizer, Inc."
Results 1 - 20 of 523
Sorted by Relevance | Sort by Date
2 Oct, 2008 4:27 am
... in Peapack, New Jersey. (Am. Compl. 9). In April 2003, Pharmacia was acquired by Pfizer, Inc. (Am. Compl. 10). Rost alleges that beginning in 1997, and continuing to
... , after nearly three years of investigation, the government declined to intervene in the case. Id. Pfizer moved to dismiss Dr. Rost's complaint for lack of subject matter
jurisdiction under ... need not consider "bald assertions [or] unsupportable conclusions." Doyle v. Hasbro, Inc., 103 F.3 186, 190 (1st Cir. 1996) (citation omitted). ...
3 Feb 1:40 am
Pfizer Inc.'s Wyeth acquisition perverts the U.S. government's Troubled Asset Relief Program, relying on loans from five banks aided by the bailout for a deal ...
departments didn't immediately return calls seeking comment. Ray Kerins, a Pfizer spokesman, said he couldn't respond to the complaint because he hadn ... interview. The
complaints are unlikely to delay the deal, though they will create "perception problems" for Pfizer in the future, said Les Funtleyder, a Miller Tabak & Co. analyst in New
...
18 Jun, 2008 1:48 pm
... of changes and turmoil over the last few months. First Alan Hesketh, Pfizer Inc.'s vice president and global head of patents was charged with child pornography ... I
set out to find out if those rumors had surfaced outside Pfizer. And lo and behold, turns out those allegations had already ... a complete erosion of trust in senior management.
So in that context these allegations inside Pfizer are informative. And the fact that the legal department is in this situation is even more noteworthy, considering ...
17 Nov 5:00 am
The Court of Appeal for the Second Appellate District, Division Three, has scheduled oral argument in Pfizer v. Superior Court (Galfano), no. B188106, one of the Tobacco II
"grant and hold" cases. The argument will take ... pursuant to Rule of Court 8.200(b)(1) as well as the two amicus briefs: Supplemental Brief of Real Party in Interest Steve Galfano
(filed 09/03/09) Supplemental Brief of Petitioner Pfizer, Inc. (filed 09/18/09) Amicus Curiae Brief of Chamber of Commerce of the U.S. (filed 09/22/ ...
22 May, 2007 9:52 pm
By Donald Zuhn -- On Monday, the Federal Circuit denied a combined petition for panel rehearing and rehearing en banc filed by Plaintiff-Appellee Pfizer, Inc. The Federal
Circuit's denial of Pfizer's petition for rehearing en banc was not unanimous, with Judges Newman, Lourie, and Rader each writing their own dissent....
20 Oct, 2008 6:47 am
Reaching an $894 million deal, drug giant Pfizer Inc has settled most of its lawsuits over the withdrawal of its pain reliever Bextra which has been linked to an elevated
risk of heart attacks and strokes. Not having to pay as much as its rival, Merck & Co, Pfizer is planning on ending 92 percent of its law suits with this agreement. To read
the complete article click here.
15 May 9:15 am
Pharmaceutical giant, Pfizer Inc, will disclose its compensation paid to U.S. healthcare professionals for consulting, speaking engagements and clinical trials. The
disclosure will include payments made to practicing U.S. physicians and other healthcare providers, as well as principal investigators, major academic institutions and research sites
for clinical research. This makes Pfizer the first biopharmaceutical company to [...]
14 Apr, 2008 5:01 pm
CNFed. Civ y Com., sala II, 11/03/99, Pfizer Inc. c. Finadiet S.A. Arraigo. Naturaleza jurídica. Medida cautelar. Monto. Criterios para su fijación. Plazo. Domicilio del
actor en EUA. Ampliación. Publicado en LL 2000-A, 389 y en DJ 2000-1, 861. 2º instancia.- Buenos Aires, marzo 11 de 1999.- Considerando: I. Que, no obstante su regulación como defensa
previa, la excepción "sub examen" es, por su naturaleza, una medida cautelar concedida al demandado ( ...
17 Nov, 2008 2:00 pm
On October 31, 2008, the Supreme Court gave itself an extension of time, through December 4, 2008, to grant or deny review in Clayworth v. Pfizer, Inc., no. S166435.
Clayworth is an interesting case that I did not have time...
20 Nov, 2008 2:00 pm
Yesterday, the Supreme Court granted review in Clayworth v. Pfizer, Inc., no. S166435. In Clayworth, the Court of Appeal held that the "pass-on" defense applied to a
price-fixing case brought by intermediate purchasers under California's Cartwright Act, and also that...
24 Nov, 2008 2:00 pm
The Supreme Court has posted its statement of issues on review in Clayworth v. Pfizer, Inc., no. S166435. The UCL-related issues are particularly interesting: (1) When
plaintiffs pay overcharges on goods or services as a result of the anticompetitive conduct...
2 Oct, 2008 6:00 am
... the old joke about how many lawyers it takes to change a light bulb. So, who were the Pfizer lawyers that were involved in the internal decisions that led to Dr. Rost finding
no recourse but to file a qui tam suit about illegal marketing, which has resulted in Pfizer paying a $35 million fine as well as the recent court order to allow Rost's ... , if
they felt safe, why have all the lawyers? And based on Pfizer's privilige log, the Peter Rost blog has the answer to who those lawyers were: ...
10 Mar, 2008 9:54 pm
By Kevin E. Noonan -- On Friday, the Court of Appeals for the Federal Circuit handed Pfizer a mixed decision on defendant Teva's appeal of a District Court judgment that Teva was
liable for infringing a trio of Pfizer patents (U.S. Patent Nos. 5,466,823; 5,563,165; and 5,760,068) relating to the...
5 Jun, 2008 6:29 pm
So I heard this on the street . . . Kindler's secret plan for Pfizer is not to get the stock up . . . that's virtually impossible, and he knows it. Solution: Drive the stock down
to below $14, enough to get the sharks circling, then accept a take-over offer for $22, and cash in all executive management parachutes. You heard it here first.By accessing this site,
you are agreeing to comply with and be bound by the terms of use agreement and privacy policy.
25 Mar, 2007 6:04 pm
By Donald Zuhn --- In an appeal from a District Court judgment of validity, enforceability, and infringement, the Federal Circuit reversed the District Court's finding of validity,
holding that U.S. Patent No. 4,879,303 (the '303 patent) was rendered obvious by, inter alia, U.S. Patent No. 4,572,909 (the '909 patent) and...
24 Nov 1:11 am
Three days after awarding $6.3 million in compensation, a Pennsylvania jury determined Pfizer Inc. will have to pay $28 million in punitive damages to a 66-year-old Donna
... In cases like these, the jury send s a message that not only sure Pfizer and other companies not only compensate victims but should be punished by ... consequences in lieu of
profits. Members of the jury said after the trial that the evidence showed Pfizer units Wyeth and Pharmacia & Upjohn dismissed opinions that their hormone ...
23 Nov 11:53 pm
Two Pfizer Inc. units' hormone- replacement therapy drugs caused an Illinois woman's breast cancer, making them liable for at least $6.3 million in damages, a ... for
trial so far, and 19 have been thrown out by judges or withdrawn by plaintiffs, according to Pfizer officials. Wyeth also has settled at least five cases over the drugs. The case
is Kendall v. Wyeth Pharmaceuticals Inc., 040600965, Court of Common Pleas, Philadelphia County, Pennsylvania. If you or a family member has been personally ...
29 Apr 2:06 am
... waived by private agreement without judicial or governmental supervision. 5. Release of claims by Pfizer. a. In consideration of and in exchange for Dr. Goodman's acceptance
of this Agreement and the obligations ... PH.D. /s/ Corey S. Goodman Dated: April 27, 2009. PFIZER INC By: /s/ Amy W. Schulman Amy W. Schulman, Senior Vice ... 25, 2009
(the "Agreement"), including but not necessarily limited to the acceptance by Pfizer Inc ("Pfizer") of my resignation effective May 31, 2009 (my "Resignation Date
...
23 Nov 3:14 am
A Pennsylvania jury has ruled that two Pfizer Inc. units areliable for at least $6.3 million in compensatory damages to an Illinois woman who developed breast cancer after
she began taking the menopause drugs Prempro and Provera ... prevailed in the "vast majority" of hormone therapy cases set for trial. Earlier in November, a jury in the same court
ordered Pfizer to fork over $75 million in punitive damages to bellwether plaintiff Connie Barton, who developed invasive breast cancer after she began ...
25 Jan 2:36 pm
... Shannon Pettypiece, Tom Randall and Zachary Mider Jan. 25 (Bloomberg) -- Pfizer Inc. would pay about $66.8 billion to acquire Wyeth in a bid being reviewed ... Promise
and Peril The Wyeth transaction carries both promise and peril for Pfizer, analysts and investors said in interviews since talks were first reported ... over the previous five
years. McKinnell, while being groomed as CEO in 2001, was instrumental in Pfizer's $115 billion acquisition of Warner- Lambert Co., the developer of Lipitor. After ...
Search on: Blawgs.FM | BlawgSearch Google Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!